Published in Nat Genet on August 01, 2001
Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet (2001) 10.48
Haplotype inference in random population samples. Am J Hum Genet (2002) 8.07
Whole-genome molecular haplotyping of single cells. Nat Biotechnol (2010) 6.77
Gametic phase estimation over large genomic regions using an adaptive window approach. Hum Genomics (2003) 4.63
Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet (2002) 2.88
The first linkage disequilibrium (LD) maps: delineation of hot and cold blocks by diplotype analysis. Proc Natl Acad Sci U S A (2002) 2.80
Digital genotyping and haplotyping with polymerase colonies. Proc Natl Acad Sci U S A (2003) 2.77
Minimum-recombinant haplotyping in pedigrees. Am J Hum Genet (2002) 2.58
Direct determination of molecular haplotypes by chromosome microdissection. Nat Methods (2010) 2.21
Little loss of information due to unknown phase for fine-scale linkage-disequilibrium mapping with single-nucleotide-polymorphism genotype data. Am J Hum Genet (2004) 2.06
Understanding the accuracy of statistical haplotype inference with sequence data of known phase. Genet Epidemiol (2007) 1.87
A comprehensive literature review of haplotyping software and methods for use with unrelated individuals. Hum Genomics (2005) 1.84
Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res (2004) 1.74
Haplotype and missing data inference in nuclear families. Genome Res (2004) 1.69
Power comparisons between similarity-based multilocus association methods, logistic regression, and score tests for haplotypes. Genet Epidemiol (2009) 1.68
Incorporating genotyping uncertainty in haplotype inference for single-nucleotide polymorphisms. Am J Hum Genet (2004) 1.66
Clone-based systematic haplotyping (CSH): a procedure for physical haplotyping of whole genomes. Genome Res (2003) 1.45
Whole-genome haplotyping by dilution, amplification, and sequencing. Proc Natl Acad Sci U S A (2013) 1.44
Entropy-based SNP selection for genetic association studies. Hum Genet (2003) 1.36
Direct determination of haplotypes from single DNA molecules. Nat Methods (2009) 1.30
Integration of association statistics over genomic regions using Bayesian adaptive regression splines. Hum Genomics (2003) 1.28
Molecular haplotyping at high throughput. Nucleic Acids Res (2002) 1.27
Long-range multilocus haplotype phasing of the MHC. Proc Natl Acad Sci U S A (2006) 1.12
Sequencing of isolated sperm cells for direct haplotyping of a human genome. Genome Res (2013) 1.11
On the use of haplotype phylogeny to detect disease susceptibility loci. BMC Genet (2005) 1.10
Are molecular haplotypes worth the time and expense? A cost-effective method for applying molecular haplotypes. PLoS Genet (2006) 1.09
Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes. Nucleic Acids Res (2005) 1.06
Single-molecule analysis for molecular haplotyping. Hum Mutat (2004) 1.06
Haplotype block partition with limited resources and applications to human chromosome 21 haplotype data. Am J Hum Genet (2003) 0.96
Evaluation of the SNP tagging approach in an independent population sample--array-based SNP discovery in Sami. Hum Genet (2007) 0.92
Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics (2008) 0.92
Efficacy assessment of SNP sets for genome-wide disease association studies. Nucleic Acids Res (2007) 0.90
The value of molecular haplotypes in a family-based linkage study. Am J Hum Genet (2006) 0.86
Gold nanoparticles for high-throughput genotyping of long-range haplotypes. Nat Nanotechnol (2011) 0.85
Glucocorticoid receptor gene variant in the 3' untranslated region is associated with multiple measures of blood pressure. J Clin Endocrinol Metab (2008) 0.85
Association mapping by generalized linear regression with density-based haplotype clustering. Genet Epidemiol (2009) 0.82
Determination of haplotypes at structurally complex regions using emulsion haplotype fusion PCR. BMC Genomics (2012) 0.82
Shotgun haplotyping: a novel method for surveying allelic sequence variation. Nucleic Acids Res (2005) 0.78
Complementarity of Binding Motifs is a General Property of HLA-A and HLA-B Molecules and Does Not Seem to Effect HLA Haplotype Composition. Front Immunol (2013) 0.78
NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles. BMC Bioinformatics (2008) 0.78
A hidden Markov model for haplotype inference for present-absent data of clustered genes using identified haplotypes and haplotype patterns. Front Genet (2014) 0.78
SNP haplotype mapping in a small ALS family. PLoS One (2009) 0.77
DNA origami-based shape IDs for single-molecule nanomechanical genotyping. Nat Commun (2017) 0.75
A Simple PCR-RFLP Method for Genetic Phase Determination in Compound Heterozygotes. Front Genet (2012) 0.75
A simple method for gene phasing using mate pair sequencing. BMC Med Genet (2014) 0.75
Recent Advances in Experimental Whole Genome Haplotyping Methods. Int J Mol Sci (2017) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol (1988) 13.73
Expression profiling using cDNA microarrays. Nat Genet (1999) 11.58
Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
How many polymorphic genes will it take to span the human genome? Am J Hum Genet (1982) 5.11
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Loss of information due to ambiguous haplotyping of SNPs. Nat Genet (1999) 4.90
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res (2001) 4.51
Improved inference of relationship for pairs of individuals. Am J Hum Genet (2000) 4.47
Estimating the power of a proposed linkage study for a complex genetic trait. Am J Hum Genet (1989) 4.42
Identification of an amplified, highly expressed gene in a human glioma. Science (1987) 4.21
KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst (1996) 4.16
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
Two-trait-locus linkage analysis: a powerful strategy for mapping complex genetic traits. Am J Hum Genet (1993) 3.76
Extensions to pedigree analysis. V. Optimal calculation of Mendelian likelihoods. Hum Hered (1983) 3.74
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A (1998) 3.35
A multipoint method for detecting genotyping errors and mutations in sibling-pair linkage data. Am J Hum Genet (2000) 3.22
Extensions to pedigree analysis. IV. Covariance components models for multivariate traits. Am J Med Genet (1983) 3.10
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Identifying marker typing incompatibilities in linkage analysis. Am J Hum Genet (1996) 3.06
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Estimating the power of a proposed linkage study: a practical computer simulation approach. Am J Hum Genet (1986) 2.84
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene (2007) 2.83
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A (1999) 2.77
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73
Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily. DNA (1987) 2.67
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc Natl Acad Sci U S A (1999) 2.53
Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA (1993) 2.51
Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res (1985) 2.50
Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene (1997) 2.35
Direct cloning of human ovarian carcinoma cells in agar. Cancer Res (1978) 2.24
Statistical methods for polyploid radiation hybrid mapping. Genome Res (1995) 2.15
Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet (1987) 2.12
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet (1994) 2.09
Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci U S A (1982) 2.08
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A (1993) 2.08
Affected-sib-pair interval mapping and exclusion for complex genetic traits: sampling considerations. Genet Epidemiol (1996) 2.06
Genetic linkage analysis of complex genetic traits by using affected sibling pairs. Biometrics (1998) 2.04
Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet (1989) 1.99
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol (2001) 1.95
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem (1999) 1.92
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis. Am J Hum Genet (1993) 1.90
Ascertainment and goodness of fit of variance component models for pedigree data. Prog Clin Biol Res (1984) 1.89
Multivariate measurement of gene expression relationships. Genomics (2000) 1.88
A look at linkage disequilibrium. Nat Genet (2000) 1.87
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol (2001) 1.72
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Genet Cytogenet (1999) 1.71
Is physician detection associated with thinner melanomas? JAMA (1999) 1.66
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A (2000) 1.66
Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression. Thromb Haemost (2000) 1.63
Expression profiling in cancer using cDNA microarrays. Electrophoresis (1999) 1.58
DNA microarray technology: the anticipated impact on the study of human disease. Biochim Biophys Acta (1999) 1.54
Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat (1987) 1.54
Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res (1991) 1.50
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A (1994) 1.50
General nonlinear framework for the analysis of gene interaction via multivariate expression arrays. J Biomed Opt (2000) 1.49
Localization of a gene for Duane retraction syndrome to chromosome 2q31. Am J Hum Genet (1999) 1.46
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci U S A (1995) 1.44
Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq. Am J Hum Genet (1994) 1.44
Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science (1988) 1.44
Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res (1988) 1.43
Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-closure glaucoma maps to chromosome 11. Am J Hum Genet (1998) 1.40
The effects of conditioning on probands to correct for multiple ascertainment. Am J Hum Genet (1984) 1.40
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet (2001) 1.40
Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer (2000) 1.39
AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci U S A (1997) 1.38
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res (1983) 1.37
Two models for a maternal factor in the inheritance of Huntington disease. Am J Hum Genet (1983) 1.37
Rapid generation of region specific probes by chromosome microdissection and their application. Nat Genet (1992) 1.35
Approach to genotyping errors caused by nontemplated nucleotide addition by Taq DNA polymerase. Genome Res (1995) 1.33
Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet (1989) 1.32
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet (2001) 1.32
Amplification units containing human N-myc and c-myc genes. Proc Natl Acad Sci U S A (1986) 1.31
Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer (1991) 1.31
Simulation of cDNA microarrays via a parameterized random signal model. J Biomed Opt (2002) 1.28
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res (1997) 1.27
The frequency of C4B variants of complement in familial and sporadic Alzheimer disease. Alzheimer Dis Assoc Disord (1987) 1.27
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet (2000) 1.27
Generation of band-specific painting probes from a single microdissected chromosome. Hum Mol Genet (1993) 1.27
Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res (1996) 1.27
Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res (2000) 1.26
The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci U S A (1993) 1.26
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res (1999) 1.25
Experimental design and error detection for polyploid radiation hybrid mapping. Genome Res (1995) 1.24